Company Of The Day: Roche

December 6th, 2021 by Trefis Team
+17.76%
Upside
30.91
Market
36.40
Trefis
RHHBY: Roche logo
RHHBY
Roche

What?

Healthcare major Roche (OTMKTS:RHHBY) says that it has developed a new PCR test kit to detect the new omicron variant of the coronavirus, which has been denoted a “variant of concern” by the World Health Organization.

Why?

Relevant Articles
  1. Is Roche Stock Undervalued At $33?
  2. What’s Driving Roche Stock?
  3. Company Of The Day: Roche Holdings
  4. What’s Happening With Roche (RHHBY) Stock?
  5. What’s Next For Roche Stock?
  6. Should You Buy, Sell, Or Hold Roche Stock At $42?

While widely available Covid-19 tests can detect infections, most tests can’t distinguish between Omicron and other variants. The new test from Roche’s recently acquired subsidiary TIB Molbiol could address this issue.

So What?

While we don’t expect this development to be very material to Roche’s stock, it could enable governments and researchers to better understand the spread and behavior of the concerning new variant.

See Our Complete Analysis For Roche

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.

Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates